Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
SPRY
Stock Latest News
Pre-Earnings
SPRY Earnings this Week: How Will it Perform?
5h ago
SPRY
Premium
The Fly
DraftKings, Flutter downgraded: Wall Street’s top analyst calls
4d ago
CV
WM
Premium
The Fly
ARS Pharmaceuticals launches ‘Get neffy on Us’
4d ago
SPRY
Premium
The Fly
ARS Pharmaceuticals resumed with a Buy at Roth Capital
4d ago
SPRY
Premium
Company Announcements
Ars Pharmaceuticals’ Latest Study: A Potential Game-Changer in Allergy Treatment
12d ago
SPRY
Premium
Company Announcements
Ars Pharmaceuticals’ Promising Study on ARS-2 for Chronic Urticaria: What Investors Need to Know
12d ago
SPRY
Premium
The Fly
ARS Pharmaceuticals receives favorable decision from EPO on neffy
1M ago
SPRY
Premium
Ratings
ARS Pharmaceuticals: Strategic Financial Maneuvers and Market Potential Drive Buy Rating
1M ago
SPRY
Premium
Company Announcements
ARS Pharmaceuticals Secures $250 Million Credit Agreement
1M ago
8K
SPRY
Premium
Ratings
ARS Pharmaceuticals Gains Momentum: Buy Rating Justified by Market Share and Script Volume Increase
1M ago
SPRY
Premium
The Fly
Raymond James positive on ARS Pharmaceuticals after weekly data
1M ago
SPRY
Premium
Market News
3 Best Stocks to Buy Now, 9/23/2025, According to Top Analysts
2M ago
ADVM
ATAI
Premium
Ratings
Global Expansion and Strategic Advancements Drive Buy Rating for ARS Pharmaceuticals
2M ago
SPRY
Premium
The Fly
ARS Pharmaceuticals announces neffy approved in Japan
2M ago
SPRY
Premium
Ratings
ARS Pharmaceuticals: Strengthened Buy Rating Following Positive Real-World Data on Neffy
2M ago
SPRY
Premium
The Fly
ARS Pharmaceuticals announces real-world evidence on neffy effectiveness
2M ago
SPRY
Premium
The Fly
Roth starts ARS Pharmaceuticals at Buy, sees ‘vast improvement’ from Neffy
2M ago
SPRY
Premium
The Fly
ARS Pharmaceuticals initiated with a Buy at Roth Capital
2M ago
SPRY
Premium
The Fly
Short Report: C3.AI short positioning at 2025-high
2M ago
AI
TEM
Premium
Company Announcements
Ars Pharmaceuticals Reports Strong Q2 Growth and Global Expansion
2M ago
SPRY
Premium
Company Announcements
ARS Pharmaceuticals Faces Patent Challenge from Lupin
2M ago
8K
SPRY
Premium
Ratings
ARS Pharmaceuticals: Strong Market Position and Growth Potential Justify Buy Rating
3M ago
SPRY
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
